First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
{{output}}
Introduction: Breast cancer (BC) is the commonest cancer among females worldwide. Some patients present initially at advanced stages and more than 50% of them will develop metastasis (MBC) at some point. Compared to single agents... ...
